Thomas Garite - Aug 26, 2021 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
VP, Clinical Sciences
Signature
/s/ Nishant Dharia, Attorney-in-fact
Stock symbol
SERA
Transactions as of
Aug 26, 2021
Transactions value $
$0
Form type
4
Date filed
9/9/2021, 05:49 PM
Previous filing
Jul 14, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SERA Stock Option (right to buy) Award $0 +10K $0.00 10K Aug 26, 2021 Class A Common Stock 10K $9.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to this option will vest monthly beginning on September 26, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date.